News Perspectives

New Home Test Finds Most Colon Cancers

U.S. regulators have approved a new home test that detects more than 90% of colorectal cancers. The Food and Drug Administration (FDA) approved the Cologuard test August 11. Like the older fecal occult test, Cologuard checks for microscopic amounts of blood in stool. But the new test also looks for abnormal DNA. This helps to find cancers that don't bleed. The test is done at home. The person collects a stool sample and mails it to a laboratory for analysis. In a study, nearly 10,000 men and women were given 3 types of tests: a fecal occult test, the Cologuard test and a colonoscopy. Colonoscopy is considered the most accurate test for colorectal cancer. It uses an instrument to look inside the colon. Cologuard detected 92% of the cancers that colonoscopy found. The fecal occult test detected 74%.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In